Viewing Study NCT00784550


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-29 @ 7:16 PM
Study NCT ID: NCT00784550
Status: COMPLETED
Last Update Posted: 2016-11-23
First Post: 2008-10-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Spirometry View
None COPD View